News Headlines Article

Overlook this Sector and It Could Cost You
SmallCapInvestor.com

When President Obama’s healthcare reform bill passed in late March 2010, name- brand pharmaceutical companies immediately scrambled. The timing could not have been worse. Most branded pharmaceutical companies were already nervous about the lack of branded drugs in the pipeline.

They were all privy to the fact that during 2011 and 2012 several best-selling, brand name drugs were losing their patent protection.

Commands